pakistan
Sun Pharma to acquire Innovcare Lifesciences for $28.7 million
Key takeaways
- Add ARY News on Google AAResize Sun Pharmaceutical Industries (Sun Pharma) on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about 2.71 billion rupees ($28.73 million).
- The company said the acquisition will help strengthen its portfolio in the specialty and branded generics segment while supporting its long-term growth strategy in both domestic and international markets.
- The acquisition, characterized by India’s largest drugmaker as a strategic investment to strengthen its product portfolio, is expected to close on or before July 31, 2026, subject to customary closing conditions.
Why this matters: local context for readers following news across Pakistan and the region.
Add ARY News on Google AAResize Sun Pharmaceutical Industries (Sun Pharma) on Saturday said it will acquire 100% of Innovcare Lifesciences in a deal valued at about 2.71 billion rupees ($28.73 million).
The company said the acquisition will help strengthen its portfolio in the specialty and branded generics segment while supporting its long-term growth strategy in both domestic and international markets.
The acquisition, characterized by India’s largest drugmaker as a strategic investment to strengthen its product portfolio, is expected to close on or before July 31, 2026, subject to customary closing conditions.
Article preview — originally published by ARY News. Full story at the source.
Read full story on ARY News →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from ARY News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop